nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—FGFR2—skull—pharynx cancer	0.0291	0.0558	CbGeAlD
Regorafenib—FGFR2—mouth—pharynx cancer	0.0101	0.0193	CbGeAlD
Regorafenib—FRK—lymphoid tissue—pharynx cancer	0.00984	0.0189	CbGeAlD
Regorafenib—EPHX2—parotid gland—pharynx cancer	0.00927	0.0178	CbGeAlD
Regorafenib—RET—neck—pharynx cancer	0.00906	0.0174	CbGeAlD
Regorafenib—DDR2—lymphoid tissue—pharynx cancer	0.00883	0.0169	CbGeAlD
Regorafenib—FGFR2—neck—pharynx cancer	0.00861	0.0165	CbGeAlD
Regorafenib—DDR2—spinal cord—pharynx cancer	0.008	0.0153	CbGeAlD
Regorafenib—FLT1—neck—pharynx cancer	0.00798	0.0153	CbGeAlD
Regorafenib—RAF1—neck—pharynx cancer	0.00793	0.0152	CbGeAlD
Regorafenib—DDR2—head—pharynx cancer	0.00711	0.0136	CbGeAlD
Regorafenib—KIT—mouth—pharynx cancer	0.00699	0.0134	CbGeAlD
Regorafenib—FLT4—epithelium—pharynx cancer	0.00698	0.0134	CbGeAlD
Regorafenib—EPHA2—parotid gland—pharynx cancer	0.00689	0.0132	CbGeAlD
Regorafenib—KDR—neck—pharynx cancer	0.00674	0.0129	CbGeAlD
Regorafenib—MAPK11—head—pharynx cancer	0.00674	0.0129	CbGeAlD
Regorafenib—FGFR2—saliva-secreting gland—pharynx cancer	0.00671	0.0129	CbGeAlD
Regorafenib—EPHA2—saliva-secreting gland—pharynx cancer	0.0066	0.0127	CbGeAlD
Regorafenib—FGFR2—brainstem—pharynx cancer	0.00658	0.0126	CbGeAlD
Regorafenib—FLT1—parotid gland—pharynx cancer	0.0065	0.0125	CbGeAlD
Regorafenib—RAF1—parotid gland—pharynx cancer	0.00646	0.0124	CbGeAlD
Regorafenib—FLT1—saliva-secreting gland—pharynx cancer	0.00622	0.0119	CbGeAlD
Regorafenib—RAF1—saliva-secreting gland—pharynx cancer	0.00619	0.0119	CbGeAlD
Regorafenib—RET—epithelium—pharynx cancer	0.00616	0.0118	CbGeAlD
Regorafenib—RAF1—brainstem—pharynx cancer	0.00606	0.0116	CbGeAlD
Regorafenib—KIT—neck—pharynx cancer	0.00598	0.0115	CbGeAlD
Regorafenib—FGFR2—epithelium—pharynx cancer	0.00586	0.0112	CbGeAlD
Regorafenib—PDGFRB—neck—pharynx cancer	0.00584	0.0112	CbGeAlD
Regorafenib—EPHA2—epithelium—pharynx cancer	0.00576	0.011	CbGeAlD
Regorafenib—TEK—epithelium—pharynx cancer	0.00561	0.0108	CbGeAlD
Regorafenib—KDR—parotid gland—pharynx cancer	0.00549	0.0105	CbGeAlD
Regorafenib—FLT1—epithelium—pharynx cancer	0.00543	0.0104	CbGeAlD
Regorafenib—RAF1—epithelium—pharynx cancer	0.0054	0.0103	CbGeAlD
Regorafenib—FLT4—lymphoid tissue—pharynx cancer	0.00538	0.0103	CbGeAlD
Regorafenib—KDR—saliva-secreting gland—pharynx cancer	0.00526	0.0101	CbGeAlD
Regorafenib—EPHA2—trachea—pharynx cancer	0.00509	0.00976	CbGeAlD
Regorafenib—DDR2—lymph node—pharynx cancer	0.00498	0.00955	CbGeAlD
Regorafenib—KIT—parotid gland—pharynx cancer	0.00487	0.00933	CbGeAlD
Regorafenib—FGFR1—spinal cord—pharynx cancer	0.00481	0.00922	CbGeAlD
Regorafenib—FLT1—trachea—pharynx cancer	0.0048	0.00921	CbGeAlD
Regorafenib—RAF1—trachea—pharynx cancer	0.00477	0.00915	CbGeAlD
Regorafenib—PDGFRB—parotid gland—pharynx cancer	0.00475	0.00912	CbGeAlD
Regorafenib—RET—lymphoid tissue—pharynx cancer	0.00475	0.0091	CbGeAlD
Regorafenib—MAPK11—lymph node—pharynx cancer	0.00472	0.00905	CbGeAlD
Regorafenib—KIT—saliva-secreting gland—pharynx cancer	0.00466	0.00894	CbGeAlD
Regorafenib—KDR—epithelium—pharynx cancer	0.00459	0.0088	CbGeAlD
Regorafenib—KIT—brainstem—pharynx cancer	0.00457	0.00876	CbGeAlD
Regorafenib—PDGFRB—saliva-secreting gland—pharynx cancer	0.00455	0.00873	CbGeAlD
Regorafenib—PDGFRA—trachea—pharynx cancer	0.0045	0.00863	CbGeAlD
Regorafenib—EPHA2—lymphoid tissue—pharynx cancer	0.00443	0.0085	CbGeAlD
Regorafenib—FLT4—head—pharynx cancer	0.00433	0.00831	CbGeAlD
Regorafenib—TEK—lymphoid tissue—pharynx cancer	0.00432	0.00829	CbGeAlD
Regorafenib—RET—spinal cord—pharynx cancer	0.0043	0.00825	CbGeAlD
Regorafenib—ABL1—parotid gland—pharynx cancer	0.00424	0.00813	CbGeAlD
Regorafenib—FLT1—lymphoid tissue—pharynx cancer	0.00418	0.00802	CbGeAlD
Regorafenib—RAF1—lymphoid tissue—pharynx cancer	0.00416	0.00797	CbGeAlD
Regorafenib—FGFR2—spinal cord—pharynx cancer	0.00409	0.00784	CbGeAlD
Regorafenib—KIT—epithelium—pharynx cancer	0.00407	0.0078	CbGeAlD
Regorafenib—ABL1—saliva-secreting gland—pharynx cancer	0.00406	0.00778	CbGeAlD
Regorafenib—KDR—trachea—pharynx cancer	0.00406	0.00778	CbGeAlD
Regorafenib—ABL1—brainstem—pharynx cancer	0.00398	0.00762	CbGeAlD
Regorafenib—PDGFRB—epithelium—pharynx cancer	0.00397	0.00762	CbGeAlD
Regorafenib—TEK—spinal cord—pharynx cancer	0.00392	0.00752	CbGeAlD
Regorafenib—PDGFRA—lymphoid tissue—pharynx cancer	0.00392	0.00751	CbGeAlD
Regorafenib—RET—head—pharynx cancer	0.00383	0.00734	CbGeAlD
Regorafenib—FLT1—spinal cord—pharynx cancer	0.00379	0.00727	CbGeAlD
Regorafenib—RAF1—spinal cord—pharynx cancer	0.00377	0.00723	CbGeAlD
Regorafenib—FGFR2—head—pharynx cancer	0.00363	0.00697	CbGeAlD
Regorafenib—KIT—trachea—pharynx cancer	0.0036	0.0069	CbGeAlD
Regorafenib—EPHA2—head—pharynx cancer	0.00357	0.00685	CbGeAlD
Regorafenib—PDGFRA—spinal cord—pharynx cancer	0.00355	0.00681	CbGeAlD
Regorafenib—KDR—lymphoid tissue—pharynx cancer	0.00353	0.00678	CbGeAlD
Regorafenib—BRAF—lymph node—pharynx cancer	0.00352	0.00675	CbGeAlD
Regorafenib—PDGFRB—trachea—pharynx cancer	0.00351	0.00674	CbGeAlD
Regorafenib—TEK—head—pharynx cancer	0.00348	0.00668	CbGeAlD
Regorafenib—FLT1—head—pharynx cancer	0.00337	0.00646	CbGeAlD
Regorafenib—EPHX2—lymph node—pharynx cancer	0.00336	0.00645	CbGeAlD
Regorafenib—RAF1—head—pharynx cancer	0.00335	0.00642	CbGeAlD
Regorafenib—KDR—spinal cord—pharynx cancer	0.0032	0.00614	CbGeAlD
Regorafenib—PDGFRA—head—pharynx cancer	0.00316	0.00605	CbGeAlD
Regorafenib—KIT—lymphoid tissue—pharynx cancer	0.00313	0.00601	CbGeAlD
Regorafenib—ABL1—trachea—pharynx cancer	0.00313	0.006	CbGeAlD
Regorafenib—PDGFRB—lymphoid tissue—pharynx cancer	0.00306	0.00587	CbGeAlD
Regorafenib—FLT4—lymph node—pharynx cancer	0.00303	0.00582	CbGeAlD
Regorafenib—FGFR1—lymph node—pharynx cancer	0.00299	0.00574	CbGeAlD
Regorafenib—KDR—head—pharynx cancer	0.00285	0.00546	CbGeAlD
Regorafenib—KIT—spinal cord—pharynx cancer	0.00284	0.00545	CbGeAlD
Regorafenib—PDGFRB—spinal cord—pharynx cancer	0.00277	0.00532	CbGeAlD
Regorafenib—ABL1—lymphoid tissue—pharynx cancer	0.00273	0.00523	CbGeAlD
Regorafenib—RET—lymph node—pharynx cancer	0.00268	0.00514	CbGeAlD
Regorafenib—ABCG2—parotid gland—pharynx cancer	0.00267	0.00512	CbGeAlD
Regorafenib—ABCG2—saliva-secreting gland—pharynx cancer	0.00256	0.00491	CbGeAlD
Regorafenib—KIT—head—pharynx cancer	0.00252	0.00484	CbGeAlD
Regorafenib—EPHA2—lymph node—pharynx cancer	0.0025	0.0048	CbGeAlD
Regorafenib—ABL1—spinal cord—pharynx cancer	0.00247	0.00474	CbGeAlD
Regorafenib—PDGFRB—head—pharynx cancer	0.00246	0.00473	CbGeAlD
Regorafenib—TEK—lymph node—pharynx cancer	0.00244	0.00468	CbGeAlD
Regorafenib—FLT1—lymph node—pharynx cancer	0.00236	0.00452	CbGeAlD
Regorafenib—RAF1—lymph node—pharynx cancer	0.00235	0.0045	CbGeAlD
Regorafenib—PDGFRA—lymph node—pharynx cancer	0.00221	0.00424	CbGeAlD
Regorafenib—ABL1—head—pharynx cancer	0.0022	0.00421	CbGeAlD
Regorafenib—KDR—lymph node—pharynx cancer	0.00199	0.00382	CbGeAlD
Regorafenib—KIT—lymph node—pharynx cancer	0.00177	0.00339	CbGeAlD
Regorafenib—PDGFRB—lymph node—pharynx cancer	0.00173	0.00331	CbGeAlD
Regorafenib—CYP2B6—lymphoid tissue—pharynx cancer	0.00159	0.00304	CbGeAlD
Regorafenib—ABCG2—spinal cord—pharynx cancer	0.00156	0.00299	CbGeAlD
Regorafenib—ABL1—lymph node—pharynx cancer	0.00154	0.00295	CbGeAlD
Regorafenib—CYP2B6—head—pharynx cancer	0.00128	0.00245	CbGeAlD
Regorafenib—ABCB1—epithelium—pharynx cancer	0.0011	0.00211	CbGeAlD
Regorafenib—ABCB1—trachea—pharynx cancer	0.000973	0.00187	CbGeAlD
Regorafenib—ABCG2—lymph node—pharynx cancer	0.00097	0.00186	CbGeAlD
Regorafenib—ABCB1—lymphoid tissue—pharynx cancer	0.000848	0.00163	CbGeAlD
Regorafenib—ABCB1—spinal cord—pharynx cancer	0.000769	0.00147	CbGeAlD
Regorafenib—ABCB1—head—pharynx cancer	0.000683	0.00131	CbGeAlD
Regorafenib—UGT1A9—Metabolism—CNDP2—pharynx cancer	0.000485	0.00101	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CNDP2—pharynx cancer	0.000485	0.00101	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by EGFR—EGFR—pharynx cancer	0.000485	0.00101	CbGpPWpGaD
Regorafenib—FGFR1—DAP12 signaling—EGFR—pharynx cancer	0.000485	0.00101	CbGpPWpGaD
Regorafenib—PDGFRA—DAP12 signaling—EGFR—pharynx cancer	0.000483	0.00101	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.00048	0.001	CbGpPWpGaD
Regorafenib—KIT—DAP12 interactions—EGFR—pharynx cancer	0.00048	0.001	CbGpPWpGaD
Regorafenib—KIT—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00048	0.001	CbGpPWpGaD
Regorafenib—KIT—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.00048	0.001	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—B4GALT5—pharynx cancer	0.000479	0.001	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000479	0.001	CbGpPWpGaD
Regorafenib—ABCB1—lymph node—pharynx cancer	0.000478	0.000917	CbGeAlD
Regorafenib—FGFR2—Signaling by PDGF—EGFR—pharynx cancer	0.000478	0.000999	CbGpPWpGaD
Regorafenib—FGFR1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000478	0.000998	CbGpPWpGaD
Regorafenib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000476	0.000995	CbGpPWpGaD
Regorafenib—KIT—Signaling by EGFR—EGFR—pharynx cancer	0.000476	0.000995	CbGpPWpGaD
Regorafenib—FGFR1—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000475	0.000993	CbGpPWpGaD
Regorafenib—KIT—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000472	0.000986	CbGpPWpGaD
Regorafenib—MAPK11—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000472	0.000986	CbGpPWpGaD
Regorafenib—PDGFRB—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.00047	0.000982	CbGpPWpGaD
Regorafenib—PDGFRB—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.00047	0.000982	CbGpPWpGaD
Regorafenib—KIT—Signaling by PDGF—EGFR—pharynx cancer	0.00047	0.000982	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CD79A—pharynx cancer	0.000469	0.00098	CbGpPWpGaD
Regorafenib—BRAF—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000467	0.000977	CbGpPWpGaD
Regorafenib—RAF1—Senescence and Autophagy in Cancer—TP53—pharynx cancer	0.000465	0.000973	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by ERBB4—EGFR—pharynx cancer	0.000463	0.000967	CbGpPWpGaD
Regorafenib—BRAF—MAPK Signaling Pathway—TP53—pharynx cancer	0.000462	0.000965	CbGpPWpGaD
Regorafenib—FGFR1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000456	0.000953	CbGpPWpGaD
Regorafenib—FGFR1—DAP12 interactions—EGFR—pharynx cancer	0.000456	0.000953	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000456	0.000953	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000455	0.00095	CbGpPWpGaD
Regorafenib—PDGFRA—DAP12 interactions—EGFR—pharynx cancer	0.000455	0.00095	CbGpPWpGaD
Regorafenib—PDGFRA—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000455	0.00095	CbGpPWpGaD
Regorafenib—ABL1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.000453	0.000947	CbGpPWpGaD
Regorafenib—FGFR2—B Cell Activation—EGFR—pharynx cancer	0.000453	0.000946	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by EGFR—EGFR—pharynx cancer	0.000452	0.000944	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by EGFR—EGFR—pharynx cancer	0.000451	0.000942	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000448	0.000936	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000447	0.000933	CbGpPWpGaD
Regorafenib—NTRK1—Signaling by NGF—EGFR—pharynx cancer	0.000447	0.000933	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by PDGF—EGFR—pharynx cancer	0.000446	0.000932	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by PDGF—EGFR—pharynx cancer	0.000445	0.000929	CbGpPWpGaD
Regorafenib—KIT—B Cell Activation—EGFR—pharynx cancer	0.000444	0.000929	CbGpPWpGaD
Regorafenib—PDGFRB—Downstream signal transduction—EGFR—pharynx cancer	0.000442	0.000923	CbGpPWpGaD
Regorafenib—RAF1—Focal Adhesion—CCND1—pharynx cancer	0.00044	0.000919	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by FGFR—EGFR—pharynx cancer	0.00044	0.000919	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ADH7—pharynx cancer	0.000439	0.000917	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ADH7—pharynx cancer	0.000439	0.000917	CbGpPWpGaD
Regorafenib—RAF1—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000438	0.000915	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000438	0.000915	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by ERBB2—EGFR—pharynx cancer	0.000438	0.000914	CbGpPWpGaD
Regorafenib—PDGFRB—DAP12 signaling—EGFR—pharynx cancer	0.000435	0.00091	CbGpPWpGaD
Regorafenib—FGFR2—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000433	0.000905	CbGpPWpGaD
Regorafenib—MAPK11—Cellular Senescence—TP53—pharynx cancer	0.00043	0.000898	CbGpPWpGaD
Regorafenib—PDGFRA—Focal Adhesion—EGFR—pharynx cancer	0.00043	0.000898	CbGpPWpGaD
Regorafenib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000429	0.000897	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000429	0.000896	CbGpPWpGaD
Regorafenib—ABL1—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.000428	0.000895	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000428	0.000894	CbGpPWpGaD
Regorafenib—RAF1—Disease—B4GALT5—pharynx cancer	0.000427	0.000893	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000427	0.000892	CbGpPWpGaD
Regorafenib—KIT—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000425	0.000889	CbGpPWpGaD
Regorafenib—FGFR1—B Cell Activation—EGFR—pharynx cancer	0.000422	0.000881	CbGpPWpGaD
Regorafenib—PDGFRA—B Cell Activation—EGFR—pharynx cancer	0.000421	0.000879	CbGpPWpGaD
Regorafenib—RAF1—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.000419	0.000876	CbGpPWpGaD
Regorafenib—RAF1—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000419	0.000876	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CD79A—pharynx cancer	0.000418	0.000874	CbGpPWpGaD
Regorafenib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—pharynx cancer	0.000414	0.000865	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB4—EGFR—pharynx cancer	0.000412	0.000862	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CNDP2—pharynx cancer	0.000412	0.000861	CbGpPWpGaD
Regorafenib—PDGFRB—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.00041	0.000856	CbGpPWpGaD
Regorafenib—PDGFRB—DAP12 interactions—EGFR—pharynx cancer	0.00041	0.000856	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00041	0.000856	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by EGFR—EGFR—pharynx cancer	0.000406	0.000848	CbGpPWpGaD
Regorafenib—FGFR1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000404	0.000844	CbGpPWpGaD
Regorafenib—PDGFRA—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000403	0.000841	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000402	0.000841	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by PDGF—EGFR—pharynx cancer	0.000401	0.000837	CbGpPWpGaD
Regorafenib—FGFR1—MAPK Signaling Pathway—TP53—pharynx cancer	0.000399	0.000834	CbGpPWpGaD
Regorafenib—RAF1—Downstream signal transduction—EGFR—pharynx cancer	0.000394	0.000823	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR—EGFR—pharynx cancer	0.000392	0.000819	CbGpPWpGaD
Regorafenib—RAF1—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.000392	0.000819	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB2—EGFR—pharynx cancer	0.00039	0.000815	CbGpPWpGaD
Regorafenib—RAF1—DAP12 signaling—EGFR—pharynx cancer	0.000388	0.000811	CbGpPWpGaD
Regorafenib—RAF1—TGF-beta Signaling Pathway—TP53—pharynx cancer	0.000388	0.00081	CbGpPWpGaD
Regorafenib—PDGFRB—Focal Adhesion—EGFR—pharynx cancer	0.000387	0.000809	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—EGFR—pharynx cancer	0.000387	0.000808	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ADH1B—pharynx cancer	0.000385	0.000804	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ADH1B—pharynx cancer	0.000385	0.000804	CbGpPWpGaD
Regorafenib—KDR—Axon guidance—EGFR—pharynx cancer	0.000382	0.000798	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000381	0.000795	CbGpPWpGaD
Regorafenib—ABL1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.000381	0.000795	CbGpPWpGaD
Regorafenib—PDGFRB—B Cell Activation—EGFR—pharynx cancer	0.000379	0.000792	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000376	0.000785	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—TP53—pharynx cancer	0.000375	0.000783	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ADH7—pharynx cancer	0.000372	0.000778	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CD79A—pharynx cancer	0.00037	0.000773	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—B4GALT5—pharynx cancer	0.000368	0.000769	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—B4GALT5—pharynx cancer	0.000368	0.000769	CbGpPWpGaD
Regorafenib—RAF1—DAP12 interactions—EGFR—pharynx cancer	0.000365	0.000763	CbGpPWpGaD
Regorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000365	0.000763	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000365	0.000763	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—EGFR—pharynx cancer	0.000363	0.000758	CbGpPWpGaD
Regorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000363	0.000758	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR—EGFR—pharynx cancer	0.000362	0.000756	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00036	0.000752	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—EGFR—pharynx cancer	0.000359	0.000751	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000359	0.000751	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000359	0.000749	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—TP53—pharynx cancer	0.000359	0.000749	CbGpPWpGaD
Regorafenib—RAF1—Signaling by PDGF—EGFR—pharynx cancer	0.000357	0.000746	CbGpPWpGaD
Regorafenib—RAF1—Focal Adhesion—EGFR—pharynx cancer	0.000345	0.000721	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000344	0.000718	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CD79A—pharynx cancer	0.00034	0.00071	CbGpPWpGaD
Regorafenib—KIT—Immune System—CD79A—pharynx cancer	0.000334	0.000697	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—EGFR—pharynx cancer	0.000333	0.000696	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—EGFR—pharynx cancer	0.000327	0.000684	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ADH1B—pharynx cancer	0.000327	0.000683	CbGpPWpGaD
Regorafenib—MAPK11—Cellular responses to stress—TP53—pharynx cancer	0.000325	0.000679	CbGpPWpGaD
Regorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000323	0.000676	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—TP53—pharynx cancer	0.00032	0.000668	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD79A—pharynx cancer	0.000317	0.000662	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD79A—pharynx cancer	0.000316	0.00066	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000315	0.000659	CbGpPWpGaD
Regorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.000312	0.000653	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—B4GALT5—pharynx cancer	0.000312	0.000652	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—CDH1—pharynx cancer	0.000312	0.000652	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—EGFR—pharynx cancer	0.000311	0.000649	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—EGFR—pharynx cancer	0.00031	0.000647	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CDH1—pharynx cancer	0.000306	0.00064	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CNDP2—pharynx cancer	0.000302	0.000631	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—CDH1—pharynx cancer	0.000291	0.000608	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CDH1—pharynx cancer	0.00029	0.000606	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000288	0.000603	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD79A—pharynx cancer	0.000285	0.000595	CbGpPWpGaD
Regorafenib—FGFR1—Axon guidance—EGFR—pharynx cancer	0.000281	0.000587	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—EGFR—pharynx cancer	0.000279	0.000583	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD79A—pharynx cancer	0.000277	0.000579	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ADH7—pharynx cancer	0.000273	0.000571	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—EGFR—pharynx cancer	0.000273	0.000569	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CDH1—pharynx cancer	0.000261	0.000546	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000256	0.000534	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD79A—pharynx cancer	0.000254	0.00053	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—EGFR—pharynx cancer	0.000249	0.00052	CbGpPWpGaD
Regorafenib—ABL1—Axon guidance—EGFR—pharynx cancer	0.000246	0.000514	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ADH1B—pharynx cancer	0.000239	0.0005	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—EGFR—pharynx cancer	0.000234	0.00049	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CDH1—pharynx cancer	0.000233	0.000487	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—CCND1—pharynx cancer	0.000233	0.000486	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000231	0.000483	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—B4GALT5—pharynx cancer	0.000229	0.000478	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.000228	0.000477	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—EGFR—pharynx cancer	0.000225	0.00047	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000223	0.000465	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000208	0.000435	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—EGFR—pharynx cancer	0.000207	0.000432	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000206	0.000431	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADH7—pharynx cancer	0.000206	0.000431	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CDH1—pharynx cancer	0.000206	0.000431	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000203	0.000424	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADH7—pharynx cancer	0.000201	0.000421	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—EGFR—pharynx cancer	0.000201	0.000419	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000194	0.000405	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—EGFR—pharynx cancer	0.00019	0.000397	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CDH1—pharynx cancer	0.000189	0.000395	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000188	0.000393	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—EGFR—pharynx cancer	0.000187	0.00039	CbGpPWpGaD
Regorafenib—KIT—Immune System—CDH1—pharynx cancer	0.000186	0.000388	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—EGFR—pharynx cancer	0.000183	0.000382	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—EGFR—pharynx cancer	0.000182	0.000381	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000181	0.000378	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—EGFR—pharynx cancer	0.000179	0.000374	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—EGFR—pharynx cancer	0.000177	0.00037	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—EGFR—pharynx cancer	0.000177	0.000369	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000177	0.000369	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CDH1—pharynx cancer	0.000176	0.000369	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CDH1—pharynx cancer	0.000176	0.000368	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—EGFR—pharynx cancer	0.000176	0.000367	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—CCND1—pharynx cancer	0.000174	0.000363	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000173	0.000361	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—EGFR—pharynx cancer	0.00017	0.000355	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—EGFR—pharynx cancer	0.00017	0.000354	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000169	0.000353	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000165	0.000345	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000162	0.000339	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—EGFR—pharynx cancer	0.000161	0.000336	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—EGFR—pharynx cancer	0.000159	0.000333	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CDH1—pharynx cancer	0.000159	0.000331	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000158	0.000329	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—EGFR—pharynx cancer	0.000155	0.000324	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CDH1—pharynx cancer	0.000154	0.000323	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TP53—pharynx cancer	0.000153	0.00032	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—EGFR—pharynx cancer	0.000153	0.000319	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—TP53—pharynx cancer	0.000145	0.000302	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—EGFR—pharynx cancer	0.000142	0.000296	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CDH1—pharynx cancer	0.000141	0.000295	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000137	0.000287	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—EGFR—pharynx cancer	0.000136	0.000285	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—EGFR—pharynx cancer	0.000136	0.000285	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000136	0.000284	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TP53—pharynx cancer	0.000132	0.000276	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000124	0.000259	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CCND1—pharynx cancer	0.000122	0.000255	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—EGFR—pharynx cancer	0.000121	0.000252	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CCND1—pharynx cancer	0.000116	0.000241	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TP53—pharynx cancer	0.000114	0.000239	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—EGFR—pharynx cancer	0.000111	0.000231	CbGpPWpGaD
Regorafenib—BRAF—Disease—EGFR—pharynx cancer	0.00011	0.00023	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000109	0.000227	CbGpPWpGaD
Regorafenib—KIT—Immune System—EGFR—pharynx cancer	0.000109	0.000227	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000104	0.000217	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—EGFR—pharynx cancer	0.000103	0.000216	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—EGFR—pharynx cancer	0.000103	0.000215	CbGpPWpGaD
Regorafenib—FGFR2—Disease—EGFR—pharynx cancer	0.000102	0.000214	CbGpPWpGaD
Regorafenib—KIT—Disease—EGFR—pharynx cancer	0.0001	0.00021	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CCND1—pharynx cancer	9.93e-05	0.000208	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CCND1—pharynx cancer	9.84e-05	0.000206	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—EGFR—pharynx cancer	9.59e-05	0.0002	CbGpPWpGaD
Regorafenib—FGFR1—Disease—EGFR—pharynx cancer	9.52e-05	0.000199	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—EGFR—pharynx cancer	9.5e-05	0.000199	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—EGFR—pharynx cancer	9.27e-05	0.000194	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CCND1—pharynx cancer	9.12e-05	0.000191	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—EGFR—pharynx cancer	9.06e-05	0.000189	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—EGFR—pharynx cancer	9.04e-05	0.000189	CbGpPWpGaD
Regorafenib—ABL1—Immune System—EGFR—pharynx cancer	9.03e-05	0.000189	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CCND1—pharynx cancer	8.96e-05	0.000187	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—EGFR—pharynx cancer	8.56e-05	0.000179	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CCND1—pharynx cancer	8.5e-05	0.000178	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCND1—pharynx cancer	8.48e-05	0.000177	CbGpPWpGaD
Regorafenib—RAF1—Immune System—EGFR—pharynx cancer	8.26e-05	0.000173	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TP53—pharynx cancer	8.05e-05	0.000168	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—EGFR—pharynx cancer	7.79e-05	0.000163	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—EGFR—pharynx cancer	7.72e-05	0.000161	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCND1—pharynx cancer	7.64e-05	0.00016	CbGpPWpGaD
Regorafenib—RAF1—Disease—EGFR—pharynx cancer	7.63e-05	0.000159	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TP53—pharynx cancer	7.61e-05	0.000159	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—EGFR—pharynx cancer	7.16e-05	0.00015	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—EGFR—pharynx cancer	7.03e-05	0.000147	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCND1—pharynx cancer	6.81e-05	0.000142	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—EGFR—pharynx cancer	6.67e-05	0.000139	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—EGFR—pharynx cancer	6.65e-05	0.000139	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TP53—pharynx cancer	6.54e-05	0.000137	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TP53—pharynx cancer	6.48e-05	0.000135	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TP53—pharynx cancer	6.01e-05	0.000126	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—EGFR—pharynx cancer	5.99e-05	0.000125	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TP53—pharynx cancer	5.9e-05	0.000123	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TP53—pharynx cancer	5.6e-05	0.000117	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TP53—pharynx cancer	5.59e-05	0.000117	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—EGFR—pharynx cancer	5.34e-05	0.000112	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TP53—pharynx cancer	5.03e-05	0.000105	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TP53—pharynx cancer	4.48e-05	9.37e-05	CbGpPWpGaD
